A number of companies are using the lessons and technologies of traditional genomics--the microarray chief among them--to delve into the more challenging world of functional genomics and proteomics.
Integrating high-throughput proteomics into pharmaceutical R&D has shifted how laboratories approach target identification and disease modeling. Mapping complex protein networks provides a functional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results